GSK PLC purchased 37.4% of their position (1.26M shares) of GENOCEA BIOSCIENCES, INC. on the open market
Open‑market purchase worth $2.84M — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 7/30/2020ACC: 0001387131-20-006914
+2.52M
Net shares
Net buyer
$2.84M
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
2.52M acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+1.26M
Price / share
$2.25
Trade value
$2.84M
% of position
37.4%
7/24/2020
3.37M→4.63M
Total
Net shares
+1.26M
Net value
$2.84M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 7/24/2020 | P · Purchase | +1.26M | $2.25 | $2.84M | 37.4% | 3.37M | 4.63M |
| Total | +1.26M | $2.84M | ||||||
Derivative Transactions1
Warrant
Indirect
Converts to
Common Stock
Shares
+1.26M
Strike price
2.25
Held after
1.26M
Exercisable
—
7/24/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrant Indirect | Common Stock | 7/24/2020 | P · Purchase | +1.26M | 2.25 | — | 1.26M |